E-LIB Suche - Ergebnisse für: Pegram, Mark

1

Incorporating clinicopathological and molecular risk predic..:

Curigliano, Giuseppe ; Dent, Rebecca ; Llombart-Cussac, Antonio...
npj Breast Cancer. 9 (2023) 1 - p. , 2023

2

Growing Tumor Spheroids from Blood: A Breakthrough Platform..:

Pegram, Mark D ; Chang, Ying C ; Kuo, Wen-Hung...
International Journal of Cancer Care and Delivery. 3 (2023) Supplement 2 - p. , 2023

Link: https://doi.org/10.53876..

3

Estrogen/HER2 receptor crosstalk in breast cancer: combinat..:

Pegram, Mark ; Jackisch, Christian ; Johnston, Stephen R. D.
npj Breast Cancer. 9 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

4

Epidemiology, clinical outcomes, and unmet needs of patient..:

Müller, Volkmar ; Bartsch, Rupert ; Lin, Nancy U....
Cancer Treatment Reviews. 115 (2023) - p. 102527 , 2023

Link: https://doi.org/10.1016/..

5

Pertuzumab plus high-dose trastuzumab for HER2-positive bre..:

Lin, Nancy U. ; Kumthekar, Priya ; Sahebjam, Solmaz...
npj Breast Cancer. 9 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

6

Novel Therapies in Cancer: Summit on Cancer Health Disparit..:

Dandwani, Mehndi ; Pegram, Mark ; Radich, Jerry...
International Journal of Cancer Care and Delivery. 3 (2023) 2 - p. , 2023

Link: https://doi.org/10.53876..

7

Evolving perspectives on the treatment of HR+/HER2+ metasta..:

Pegram, Mark ; Pietras, Richard ; Dang, Chau T....
Therapeutic Advances in Medical Oncology. 15 (2023) - p. , 2023

Link: https://doi.org/10.1177/..

8

Role of Fcγ receptors in HER2-targeted breast cancer therap:

Musolino, Antonino ; Gradishar, William J ; Rugo, Hope S...
Journal for ImmunoTherapy of Cancer. 10 (2022) 1 - p. e003171 , 2022

Link: https://doi.org/10.1136/..

9

Combining CD47 blockade with trastuzumab eliminates HER2-po..:

Upton, Rosalynd ; Banuelos, Allison ; Feng, Dongdong...
Proceedings of the National Academy of Sciences. 118 (2021) 29 - p. , 2021

Link: https://doi.org/10.1073/..

10

Biosimilars in an Era of Rising Oncology Treatment Options:

Peeters, Marc ; Planchard, David ; Pegram, Mark...
Future Oncology. 17 (2021) 29 - p. 3881-3892 , 2021

Link: https://doi.org/10.2217/..

11

A careful reassessment of anthracycline use in curable brea..:

Hurvitz, Sara Alsterlind ; McAndrew, Nicholas P. ; Bardia, Aditya...
npj Breast Cancer. 7 (2021) 1 - p. , 2021

Link: https://doi.org/10.1038/..

12

First-in-Human, Phase 1 Dose-Escalation Study of Biparatopi..:

Pegram, Mark D. ; Hamilton, Erika P. ; Tan, Antoinette R....
Molecular Cancer Therapeutics. 20 (2021) 8 - p. 1442-1453 , 2021

Link: https://doi.org/10.1158/..

13

Advances in Therapeutic Approaches for Triple-Negative Brea..:

Mahtani, Reshma ; Kittaneh, Muaiad ; Kalinsky, Kevin...
Clinical Breast Cancer. 21 (2021) 5 - p. 383-390 , 2021

Link: https://doi.org/10.1016/..

14

RNA Based Approaches to Profile Oncogenic Pathways From Low..:

van de Stolpe, Anja ; Verhaegh, Wim ; Blay, Jean-Yves...
Frontiers in Genetics. 11 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

15

Single-cell immunoblotting resolves estrogen receptor-α iso..:

Kim, John J. ; Liang, Wenchuan ; Kang, Chi-Chih...
PLOS ONE. 16 (2021) 7 - p. e0254783 , 2021

Link: https://doi.org/10.1371/..